⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34097 | 0.79 | MEN1 (1.00) | — | |
| SCHEMBL29869345 | 0.79 | MEN1 (0.68) | — | |
| SCHEMBL713707 | 0.79 | MEN1 (0.68) | — | |
| SCHEMBL30063472 | 0.79 | MEN1 (1.00) | — | |
| SCHEMBL6187 | 0.77 | — | — | |
| SCHEMBL29351116 | 0.77 | — | — | |
| SCHEMBL5167521 | 0.77 | CYP3A4 (1.00) | — | |
| SCHEMBL6003193 | 0.77 | MEN1 (0.65) | — | |
| Hydrochloric Acid SCHEMBL3248165 | 0.77 | MEN1 (0.94) | — | |
| Hydrochloric Acid SCHEMBL8645056 | 0.77 | MEN1 (0.65) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0485458-B1 | THIOACYLATING REAGENTS AND INTERMEDIATES, THIOPEPTIDES, AND METHODS FOR PREPARING AND USING SAME | IAF BIOCHEM INT (CA) | 1997-10-22 | — | — | EP | claimed |
| EP-0485458-A1 | THIOACYLATING REAGENTS AND INTERMEDIATES, THIOPEPTIDES, AND METHODS FOR PREPARING AND USING SAME. | IAF BIOCHEM INT (CA) | 1992-05-20 | — | — | EP | claimed |
| WO-1991001976-A1 | THIOACYLATING REAGENTS AND INTERMEDIATES, THIOPEPTIDES, AND METHODS FOR PREPARING AND USING SAME | IAF BIOCHEM INTERNATIONAL INC. (CA) | 1991-02-21 | — | — | WO | claimed |
| WO-2024079468-A1 | COMPOUNDS FOR USE AS MEDICAMENTS | CHARIOT INNOVATIONS LTD (GB) | 2024-04-18 | — | — | WO | disclosed |
| WO-2023094679-A1 | PHOTODYNAMIC THERAPY AND DIAGNOSIS | RMW CHO GROUP LIMITED (CN) | 2023-06-01 | — | — | WO | disclosed |
| EP-3752492-B1 | FUNGICIDAL OXADIAZOLES | BAYER AG (DE) | 2022-12-21 | — | — | EP | disclosed |
| EP-2563759-B1 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM | CALCIMEDICA INC (US) | 2022-04-06 | — | — | EP | disclosed |
| EP-3661925-B1 | NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS | INFLAZOME LTD (IE) | 2021-11-24 | — | — | EP | disclosed |
| EP-3237419-B1 | FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE | AKARNA THERAPEUTICS LTD (GB) | 2021-02-17 | — | — | EP | disclosed |
| EP-3744710-A1 | COMPOUND, RESIN, COMPOSITION, AND PATTERN FORMING METHOD | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2020-12-02 | — | — | EP | disclosed |
| WO-2020145725-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | 주식회사 엘지화학 | 2020-07-16 | — | — | WO | disclosed |
| WO-2020138964-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | 주식회사 엘지화학 | 2020-07-02 | — | — | WO | disclosed |
| CN-111128548-A | Composite solid-state capacitor and method for manufacturing same | 钰冠科技股份有限公司 | 2020-05-08 | — | — | CN | disclosed |
| EP-2820013-B9 | LIVER X RECEPTOR (LXR) MODULATORS FOR THE TREATMENT OF DERMAL DISEASES, DISORDERS AND CONDITIONS | RALEXAR THERAPEUTICS INC (US) | 2019-01-09 | — | — | EP | disclosed |
| EP-2820013-B1 | LIVER X RECEPTOR (LXR) MODULATORS FOR THE TREATMENT OF DERMAL DISEASES, DISORDERS AND CONDITIONS | RALEXAR THERAPEUTICS INC (US) | 2018-07-11 | — | — | EP | disclosed |
| WO-2017205633-A1 | FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE | AKARNA THERAPEUTICS, LTD. (GB) | 2017-11-30 | — | — | WO | disclosed |
| US-20050277676-A1 | M3muscarinic acetylcholine receptor antagonists | GLAXO GROUP LIMITED (GB) | 2005-12-15 | — | — | US | disclosed |
| EP-1549278-A4 | M sb 3 /sb MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | GLAXO GROUP LTD (GB) | 2005-12-14 | — | — | EP | disclosed |
| EP-1549278-A2 | M sb 3 /sb MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2005-07-06 | — | — | EP | disclosed |
| WO-2004012684-A2 | M3MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2004-02-12 | — | — | WO | disclosed |